ABT vs APYX · P/E 25, rev $44.33B vs rev $48.1M
Abbott Laboratories (ABT) versus Apyx Medical Inc (APYX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Apyx Medical Inc (APYX) is a medical devices company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported APYX revenue for 2024-12-31 was $48.1M. Net income was -$23.6M. Revenue was down 8.1% from 2023-12-31 to 2024-12-31. APYX currently screens at market cap $179.6M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. APYX currently screens at market cap $179.6M.
Not investment advice. Open the ABT and APYX stock pages for the full models.
Not investment advice.